Journal article · 2018 · Open access
Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity
EJNMMI Research, 8(1), 84 · Published 22 August 2018 · DOI 10.1186/s13550-018-0440-2
In brief
“Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity” is a 2018 journal article by Martina Wirtz and 6 co-authors, published in EJNMMI Research. OpenAlex counts 42 citations as of 19 November 2026, which puts it in the top 7% of works published in 2018 by citations. It is open access under a CC BY licence: the full text is free to read at EJNMMI Research.
- Citations
- 42
- Most cited in
- 2020 (11)
- Field-weighted impact
- 3.01
- References
- 40
- Authors
- 7
Abstract
Several radiolabeled prostate-specific membrane antigen (PSMA) inhibitors based on the lysine-urea-glutamate (KuE) motif as the pharmacophore proved to be suitable tools for PET/SPECT imaging of the PSMA expression in prostate cancer patients. PSMA I&T, a theranostic tracer developed in our group, was optimized through alteration of the peptidic structure in order to increase the affinity to PSMA and internalization in PSMA-expressing tumor cells. However, further structural modifications held promise to improve the pharmacokinetic profile. Among the investigated compounds 1 – 9 , the PSMA inhibitors 5 and 6 showed the highest PSMA affinity (lowest IC 50 values) after the introduction of a naphthylalanine modification. The affinity was up to three times higher compared to the reference PSMA I&T. Extended aromatic systems such as the biphenylalanine residue in 4 impaired the interaction with the lipophilic binding pocket of PSMA, resulting in a tenfold lower affinity. The IC 50 of DOTAGA-conjugated 10 was slightly increased compared to the acetylated analog; however, efficient PSMA-mediated internalization and 80% plasma protein binding of 68 Ga- 10 resulted in effective tumor targeting and low uptake in non-target tissues of LNCaP tumor-bearing CD-1 nu/nu mice at 1 h p.i., as determined by small-animal PET imaging and biodistribution studies. For prolonged tumor retention, the plasma protein binding was increased by insertion of 4-iodo- d -phenylalanine resulting in 97% plasma protein binding and 16.1 ± 2.5% ID/g tumor uptake of 177 Lu- 11 at 24 h p.i. Higher lipophilicity of the novel PSMA ligands 10 and 11 proved to be beneficial in terms of affinity and internalization and resulted in higher tumor uptake compared to the parent compound. Additional combination with para-iodo-phenylalanine in the spacer of ligand 11 elevated the plasma protein binding and enabled sustained tumor accumulation over 24 h, increasing the tumor uptake almost fourfold compared to 177 Lu-PSMA I&T. However, high renal uptake remains a drawback and further studies are necessary to elucidate the responsible mechanism behind it.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wirtz, M., Schmidt, A., Schottelius, M., Robu, S., Günther, T., Schwaiger, M., & Wester, H. (2018). Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity. EJNMMI Research, 8(1), 84. https://doi.org/10.1186/s13550-018-0440-2
MLA 9
Wirtz, Martina, et al. “Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity.” EJNMMI Research, vol. 8, no. 1, 2018, p. 84. https://doi.org/10.1186/s13550-018-0440-2.
Chicago
Wirtz, Martina, Alexander Schmidt, Margret Schottelius, Stephanie Robu, Thomas Günther, Markus Schwaiger, and Hans‐Jürgen Wester. 2018. “Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity.” EJNMMI Research 8 (1): 84. https://doi.org/10.1186/s13550-018-0440-2.
Harvard
Wirtz, M. et al. (2018) ‘Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity’, EJNMMI Research, 8(1), p. 84. doi:10.1186/s13550-018-0440-2.
IEEE
M. Wirtz et al., “Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity,” EJNMMI Research, vol. 8, no. 1, p. 84, 2018, doi: 10.1186/s13550-018-0440-2.
BibTeX
@article{wirtz2018synthesis,
title = {{Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity}},
author = {Wirtz, Martina and Schmidt, Alexander and Schottelius, Margret and Robu, Stephanie and Günther, Thomas and Schwaiger, Markus and Wester, Hans‐Jürgen},
journal = {EJNMMI Research},
year = {2018},
volume = {8},
number = {1},
pages = {84},
doi = {10.1186/s13550-018-0440-2},
url = {https://doi.org/10.1186/s13550-018-0440-2}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 2 | |
| 2019 | 2 | |
| 2020 | 11 | |
| 2021 | 5 | |
| 2022 | 4 | |
| 2023 | 4 | |
| 2024 | 3 | |
| 2025 | 8 | |
| 2026 | 3 |
Its field-weighted citation impact is 3.01: it has been cited 3.01 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- prostate-specific membrane antigen
- PSMA inhibitors
- lipophilicity
- plasma protein binding
- 177Lu-PSMA-I&T
- prostate cancer imaging
- tumor targeting
- renal uptake
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Wirtz, M., Schmidt, A., Schottelius, M., Robu, S., Günther, T., Schwaiger, M., & Wester, H. (2018). Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity. EJNMMI Research, 8(1), 84. https://doi.org/10.1186/s13550-018-0440-2
How many times has this paper been cited?
42 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at EJNMMI Research: sign in and open the PDF from this page.
Who wrote this paper?
Martina Wirtz, Alexander Schmidt, Margret Schottelius, Stephanie Robu, Thomas Günther, Markus Schwaiger, Hans‐Jürgen Wester.
What is the DOI of this paper?
10.1186/s13550-018-0440-2, permanently at https://doi.org/10.1186/s13550-018-0440-2. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.